Nathan Usry
Internal Medicine · Mobile, ALNPI 1679151120
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 28.5% of the total.
Across 103 payments — averaging $31.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$909
- Johnson & Johnson$432
- Lilly USA, LLC$225
- Phathom Pharmaceuticals, Inc.$206
- Takeda Pharmaceuticals U.S.A., Inc.$201
- Sanofi$165
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,09697%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $909 |
| Johnson & Johnson(2 entities) | 9 | $432 |
| Lilly USA, LLC | 7 | $225 |
| Phathom Pharmaceuticals, Inc. | 7 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $201 |
| Sanofi | 6 | $165 |
| Intercept Pharmaceuticals, Inc. | 3 | $162 |
| Medtronic | 1 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $137 |
| Gilead | 2 | $132 |
| AstraZeneca | 1 | $125 |
| Boehringer Ingelheim | 1 | $90 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| ERBE USA Inc | 1 | $40 |
| Novo Nordisk | 2 | $39 |
| Ardelyx, Inc. | 2 | $37 |
| Amgen | 1 | $21 |
| Merck | 1 | $21 |
| Pfizer | 1 | $18 |
| Celltrion USA Inc. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,195 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 12 | $3,051 |
| Valsartan | 14 | $394 |
| Atorvastatin Calcium | 27 | $315 |
| Rosuvastatin Calcium | 17 | $288 |
| Carvedilol | 36 | $256 |
| Spironolactone | 14 | $199 |
| Amlodipine Besylate | 27 | $148 |
| Furosemide | 16 | $89 |
| Lisinopril | 13 | $69 |
| Metformin Hcl | 11 | $55 |
| Hydrochlorothiazide | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Mobile
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Bobby WrightsMobile$89K
- Rahel AzizMobile$67K
- Jamie CaudillMobile$52K
- Lin LiMobile$45K
- Edward CarlosMobile$26K
- Donald SandersMobile$23K
- Amy StrassburgMobile$18K
- Roger AlvaradoMobile$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.